Cargando…
Effect of glutaminase inhibition on cancer-induced bone pain
PURPOSE: The complex nature of cancer-induced bone pain (CIBP) has led to investigation into cancer-targeted therapies. This has involved targeting glutamate release from the tumor, secreted as a byproduct of antioxidant responses and metabolic disruption. Cancer cells undergo many metabolic changes...
Autores principales: | Fazzari, Jennifer, Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750878/ https://www.ncbi.nlm.nih.gov/pubmed/31571981 http://dx.doi.org/10.2147/BCTT.S215655 |
Ejemplares similares
-
Identification of capsazepine as a novel inhibitor of system x(c)(−) and cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2017) -
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain
por: Fazzari, Jennifer, et al.
Publicado: (2015) -
Bone cancer-induced pain is associated with glutamate signalling in
peripheral sensory neurons
por: Zhu, Yong Fang, et al.
Publicado: (2020) -
Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Meta-bolism to Peripheral Sensory Pain Pathways
por: Fazzari, Jennifer, et al.
Publicado: (2017) -
Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients
por: Fazzari, Jennifer, et al.
Publicado: (2020)